Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis | Financial Data & Charts

Investment Radar

Seven-Dimensional Value Assessment Based on 2025 Q4 Financials

加载雷达图...

加载图表中...

📊 Valuation

Key valuation metrics

EV/EBITDA (TTM)

i

Enterprise Value, EBITDA and Ratio

EV/EBIT (TTM)

i

Enterprise Value, EBIT and Ratio

EV/Sales (TTM)

i

Enterprise Value, Revenue and Ratio

P/E Ratio (TTM)

i

Market Cap, Net Income and Ratio

P/B Ratio (Quarterly)

i

Market Cap, Book Value and Ratio

FCF Yield (TTM)

i

FCF, Enterprise Value and Yield

PR Profit Ratio (PPM)

i

PE Ratio, ROE and Profit Ratio (PR = PE / ROE)

📈 Growth

Revenue, earnings, and per-share growth metrics

Revenue (Quarterly)

i

Quarterly Revenue

Revenue/Share (Quarterly)

i

Revenue Per Share

Net Income (Quarterly)

i

Quarterly Net Income

EPS (Quarterly)

i

Earnings Per Share

Gross Profit/Share (Quarterly)

i

Gross Profit Per Share

OCF/Share (Quarterly)

i

Operating Cash Flow Per Share

FCF/Share (Quarterly)

i

Free Cash Flow Per Share

Operating Leverage (YoY)

i

Change in Operating Income / Change in Revenue

💰 Profitability

Profit margins and return on equity

Gross Margin (TTM)

i

Revenue, Gross Profit and Gross Margin

Operating Margin (TTM)

i

Revenue, Operating Income and Operating Margin

Net Profit Margin (TTM)

i

Revenue, Net Income and Net Profit Margin

ROE (TTM)

i

Equity, Net Income and Return on Equity

ROA (TTM)

i

Assets, Net Income and Return on Assets

ROTCE - Return on Tangible Common Equity (TTM)

i

Net Income, Tangible Common Equity and ROTCE

OCF Margin (TTM)

i

Revenue, Operating Cash Flow and OCF Margin

FCF Margin (TTM)

i

Revenue, Free Cash Flow and FCF Margin

💵 Cash Quality

Cash flow quality and conversion metrics

OCF/NI Ratio (TTM)

i

Operating Cash Flow, Net Income and Ratio

FCF/NI Ratio (TTM)

i

Free Cash Flow, Net Income and Ratio

OCF/Capex (TTM)

i

Operating Cash Flow, Capex and Coverage Ratio

OCF/SBC (TTM)

i

Operating Cash Flow, SBC and Coverage Ratio

🛡️ Leverage & Liquidity

Debt, liquidity, and financial health

Debt/Equity (quarterly)

i

Total Debt, Total Equity and Debt/Equity Ratio

EBITDA/Net Debt (TTM)

i

EBITDA, Net Debt and Coverage Ratio

Interest Coverage (TTM)

i

EBIT, Interest Expense and Coverage Ratio

Current Ratio (quarterly)

i

Current Assets, Current Liabilities and Current Ratio

Quick Ratio (quarterly)

i

Quick Assets, Current Liabilities and Quick Ratio

Altman Z-Score

i

Financial Distress Prediction Model

⚙️ Ops & Cap Efficiency

Asset utilization, working capital, ROIC, and capital efficiency

ROIC (TTM)

i

NOPAT, Invested Capital and Return on Invested Capital

ROCE - Return on Capital Employed (TTM)

i

EBIT, Capital Employed and Return on Capital Employed

Asset Turnover (TTM)

i

Revenue, Total Assets and Turnover Ratio

CapEx/Depreciation - Investment Intensity (TTM)

i

CapEx, Depreciation and Ratio (>1=Expansion, <1=Contraction)

R&D/Gross Profit - R&D Intensity (TTM)

i

R&D Expenses, Gross Profit and Ratio

SG&A/Revenue - SG&A Efficiency (TTM)

i

SG&A Expenses, Revenue and Ratio

Cash Conversion Cycle (TTM)

i

DSO + DIO - DPO (in days)

DSO - Days Sales Outstanding (TTM)

i

Average Receivables and Days Sales Outstanding

DIO - Days Inventory Outstanding (TTM)

i

Average Inventory and Days Inventory Outstanding

DPO - Days Payables Outstanding (TTM)

i

Average Payables and Days Payables Outstanding

Goodwill/Assets (Quarterly)

i

Goodwill as % of Total Assets

🎁 Shareholder Returns

Dividends, share buybacks, dilution, and insider trading activity

Dividend Yield (TTM)

i

Dividend Per Share, Share Price and Dividend Yield

Buyback Yield (TTM)

i

Net Buyback and Buyback Yield

Buyback Yield (3 Years)

i

Net Buyback 3Y and Buyback Yield 3Y

Dilution Rate (1 Year)

i

Current Shares, 1Y Ago Shares and Dilution Rate

Dilution Rate (3 Years)

i

Current Shares, 3Y Ago Shares and Dilution Rate

SBC Offset Rate (TTM)

i

Buyback / Stock-Based Comp and SBC Ratio

Insider Activity Rate (TTM)

i

Insider Net Buying and Activity Rate

Profit Waterfall Analysis

加载图表中...

P

Profitability Margins

Gross Profit Margini

84.95%

Gross Profit = $3.30B

Revenue = $3.88B

Operating Profit Margini

22.65%

Operating Income = $0.88B

Revenue = $3.88B

EBITDA Margini

30.92%

EBITDA = $1.20B

Revenue = $3.88B

EBIT Margini

27.18%

EBIT = $1.04B

Revenue = $3.88B

Net Profit Margini

21.74%

Net Income = $0.84B

Revenue = $3.88B

Pretax Profit Margini

26.87%

EBT = $1.04B

Revenue = $3.88B

E

Operating Efficiency

Interest Coveragei

120.42x

EBIT (TTM) = $5.27B

Interest Expense (TTM) = $0.04B

87.6x

105.3x

134.2x

123.2x

120.4x

SG&A / Revenuei

19.95%

SG&A = $0.78B

Revenue = $3.88B

R&D / Revenuei

41.86%

R&D = $1.63B

Revenue = $3.88B

R

Return Metrics (TTM)

ROAi

11.50%

Net Income = $4.50B

Avg Total Assets = $39.16B

ROEi

14.87%

Net Income = $4.50B

Avg Equity = $30.31B

ROICi

21.21%

NOPAT (TTM) = $3.10B

Avg Invested Capital = $14.62B

(NOPAT = Operating Income × (1 - Effective Tax Rate))

(Avg IC = (Current IC + Year-Ago IC) / 2)

Revenue Growthi

2.51%

Current Revenue = $3.88B

Previous Revenue = $3.79B

+10.3%

-3.7%

+3.6%

+0.9%

+2.5%

Operating Cash Flow/Sharei

$46.32

Operating CF = $4.98B

Diluted Shares = 0.11B

$38.84

$35.55

$43.68

$47.30

$46.32

Comprehensive Analysis

Income Statement Items	YoY Growth	Current Quarter Value	Trend
Revenue	+2.5%	$3.88B	↑
Gross Profit	+6.5%	$3.30B, 84.95%	↑
Operating Income	-14.3%	$0.88B, 22.65%	↓
EBITDA	+9.7%	$1.20B, 30.92%	↑
EBT	+8.9%	$1.04B, 26.87%	↑
Net Income	-8.0%	$0.84B, 21.74%	↓
Diluted EPS	-2.5%	7.86	↓

加载图表中...

L

Liquidity Metrics

Current Ratioi

4.13

Healthy

Total Current Assets = $18.02B

Total Current Liabilities = $4.37B

Quick Ratioi

3.39

Healthy

Quick Assets = $14.82B

Total Current Liabilities = $4.37B

Cash Ratioi

1.97

Healthy

Cash & Equivalents = $8.61B

Total Current Liabilities = $4.37B

Cash Ratio = (Cash + Short-term Investments) / Current Liabilities

L

Leverage Metrics

Debt to Equityi

0.09

Healthy

Total Debt = $2.71B

Total Equity = $31.26B

Liabilities to Assetsi

22.9%

Healthy

Total Liabilities = $9.30B

Total Assets = $40.56B

Equity Multiplieri

1.30

Healthy

Total Assets = $40.56B

Total Equity = $31.26B

E

Efficiency Metrics

Asset Turnoveri

0.37

Attention

Revenue (TTM) = $14.34B

Avg Total Assets = $39.16B

Inventory Turnoveri

0.73

Attention

COGS (TTM) = $2.36B

Avg Inventory = $3.23B

Receivables Turnoveri

2.51

Attention

Revenue (TTM) = $14.34B

Avg Receivables = $5.71B

S

Solvency Metrics

Interest Coveragei

120.42

Healthy

EBIT (TTM) = $5.27B

Interest Expense (TTM) = $0.04B

Net Debt to EBITDAiNet Debt/EBITDA

-0.07

Healthy

Net Debt = $-0.41B

EBITDA (TTM) = $5.82B

Debt Service Coveragei

N/A

Normal

Operating CF (TTM) = $4.98B

Debt Service = $0.00B

V

Value Metrics

Goodwill %iGoodwill/Assets

0.0%

Healthy

Goodwill = $0.00B

Total Assets = $40.56B

Working Capital Ratioi

0.34

Healthy

Working Capital = $13.65B

Total Assets = $40.56B

加载图表中...

Cash Flow Waterfall Chart

加载图表中...

Inflow

Outflow

Subtotal

Start/End

C

Cash Flow Metrics

Operating Cash Flow TTMi

$4.98B

Free Cash Flow TTMi

$4.08B

FCF = OCF - CapEx

OCF (TTM) = $4.98B

CapEx (TTM) = $-0.90B

FCF Yieldi

5.31%

Attention

FCF (TTM) = $4.08B

Market Cap = $76.83B

OCF/Sales Ratioi

34.71%

Healthy

OCF (TTM) = $4.98B

Revenue (TTM) = $14.34B

Q

Quality & Coverage Metrics

Income Qualityi

1.11x

Normal

OCF (TTM) = $4.98B

Net Income (TTM) = $4.50B

Cash Flow/Debti

1.84x

Healthy

OCF (TTM) = $4.98B

Total Debt = $2.71B

Short Term Coveragei

1.14x

Healthy

OCF (TTM) = $4.98B

Current Liabilities = $4.37B

Capex Coveragei

5.54x

Healthy

OCF (TTM) = $4.98B

CapEx (TTM) = $0.90B

E

Efficiency Metrics

⚡ Ratios calculated in USD to eliminate exchange rate impact

FCF/OCF Ratioi

81.96%

Healthy

FCF (TTM) = $4.08B

OCF (TTM) = $4.98B

Capex/Revenuei

6.26%

Normal

CapEx (TTM) = $0.90B

Revenue (TTM) = $14.34B

Net Debt/EBITDAi

-0.07

Healthy

Net Debt = $-0.41B

EBITDA (TTM) = $5.82B

G

Growth Metrics

OCF Growthi

-7.29%

Attention

Current OCF (TTM) = $1.17B

Previous OCF = $1.26B

Owner Earningsi

$4.01B

Healthy

Net Income (TTM) = $4.50B

+ D&A (TTM) = $0.40B

- CapEx (TTM) = $-0.90B

加载图表中...

Loading...

Regeneron Pharmaceuticals, Inc.

Investment Radar

🔍 Business Model Analysis (DuPont Model)

Leading Indicators

Financial Metrics

📊 Valuation

EV/EBITDA (TTM)

EV/EBIT (TTM)

EV/Sales (TTM)

P/E Ratio (TTM)

P/B Ratio (Quarterly)

FCF Yield (TTM)

PR Profit Ratio (PPM)

📈 Growth

Revenue (Quarterly)

Revenue/Share (Quarterly)

Net Income (Quarterly)

EPS (Quarterly)

Gross Profit/Share (Quarterly)

OCF/Share (Quarterly)

FCF/Share (Quarterly)

Operating Leverage (YoY)

💰 Profitability

Gross Margin (TTM)

Operating Margin (TTM)

Net Profit Margin (TTM)

ROE (TTM)

ROA (TTM)

ROTCE - Return on Tangible Common Equity (TTM)

OCF Margin (TTM)

FCF Margin (TTM)

💵 Cash Quality

OCF/NI Ratio (TTM)

FCF/NI Ratio (TTM)

OCF/Capex (TTM)

OCF/SBC (TTM)

🛡️ Leverage & Liquidity

Debt/Equity (quarterly)

EBITDA/Net Debt (TTM)

Interest Coverage (TTM)

Current Ratio (quarterly)

Quick Ratio (quarterly)

Altman Z-Score

⚙️ Ops & Cap Efficiency

ROIC (TTM)

ROCE - Return on Capital Employed (TTM)

Asset Turnover (TTM)

CapEx/Depreciation - Investment Intensity (TTM)

R&D/Gross Profit - R&D Intensity (TTM)

SG&A/Revenue - SG&A Efficiency (TTM)

Cash Conversion Cycle (TTM)

DSO - Days Sales Outstanding (TTM)

DIO - Days Inventory Outstanding (TTM)

DPO - Days Payables Outstanding (TTM)

Goodwill/Assets (Quarterly)

🎁 Shareholder Returns

Dividend Yield (TTM)

Buyback Yield (TTM)

Buyback Yield (3 Years)

Dilution Rate (1 Year)

Dilution Rate (3 Years)

SBC Offset Rate (TTM)

Insider Activity Rate (TTM)

Income Statement Analysis

Profit Waterfall Analysis

Balance Sheet Analysis

Cash Flow Statement Analysis

📊 Valuation

EV/EBITDA (TTM)

EV/EBIT (TTM)

EV/Sales (TTM)

P/E Ratio (TTM)

P/B Ratio (Quarterly)

FCF Yield (TTM)

PR Profit Ratio (PPM)

📈 Growth

Revenue (Quarterly)

Revenue/Share (Quarterly)

Net Income (Quarterly)